Abstract
Purpose
Abdominal pain is a cardinal sign of functional bowel disorders (FBD), in favor of irritable bowel syndrome (IBS). However, the determinants of abdominal pain severity (APS) are unknown. The present study aimed to search the relationships between APS and demographic, psychological, and clinical parameters in tertiary care FBD outpatients.
Patients and Methods
In this retrospective study, we included 2043 new outpatients with FBD or functional abdominal pain. They fulfilled the Rome III questionnaire, psychological evaluation, and four 10-points Likert scale for the perceived severity of constipation, diarrhea, bloating, and abdominal pain. Linear regression was performed for each phenotype to model the severity of abdominal pain with demographic, psychological parameters, and symptoms severity.
Results
APS was positively associated with bloating severity in all phenotypes, but APS was also associated with other variables according to gender and phenotype. APS was negatively associated with age and positively with depression, constipation severity, and diarrhea severity in female patients. In male patients, APS was associated with state anxiety, constipation severity, and diarrhea severity. APS severity was associated with bloating severity and transit severity in IBS patients, while in non-IBS patients, APS was only associated with bloating severity.
Conclusion
Perceived abdominal pain severity is always associated with perceived bloating severity in FBD and FAP patients.
Similar content being viewed by others
References
1 Ruffle JK, Tinkler L, Emmett Cet al. . Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach Am J Gastroenterol. 2021;116:142-151.
Bouchoucha M, Devroede G, Fysekidis M, Rompteaux P, Sabate JM, Benamouzig R. Data mining approach for the characterization of functional bowel disorders according to symptom intensity provides a small number of homogenous groups Dig Dis. 2020;38(4):310–319.
3 Van Oudenhove L, Crowell MD, Drossman DAet al. . Biopsychosocial Aspects of Functional Gastrointestinal Disorders Gastroenterology. 2016.
4 Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV Gastroenterology. 2016.
5 Palsson OS, Whitehead W, Tornblom H, Sperber AD, Simren M. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom Gastroenterology. 2020;158:1262-1273 e1263.
6 Ng KS, Nassar N, Hamd K, Nagarajah A, Gladman MA. Prevalence of functional bowel disorders and faecal incontinence: an Australian primary care survey Colorectal Dis. 2015;17:150-159.
7 Singh P, Surana R, Soni Set al. . Cross cultural comparison of constipation profiles at tertiary care centers between India and USA Neurogastroenterol Motil. 2018.
8 Dong Y, Baumeister D, Berens S, Eich W, Tesarz J. High Rates of Non-Response Across Treatment Attempts in Chronic Irritable Bowel Syndrome: Results From a Follow-Up Study in Tertiary Care Front Psychiatry. 2019;10:714.
9 Quigley EM, Locke GR, Mueller-Lissner Set al. . Prevalence and management of abdominal cramping and pain: a multinational survey Aliment Pharmacol Ther. 2006;24:411-419.
10 Bouchoucha M, Mary F, Bon C, Bejou B, Airinei G, Benamouzig R. Sleep quality and functional gastrointestinal disorders. A psychological issue J Dig Dis. 2018;19:84-92.
11 Sperber AD, Carmel S, Atzmon Yet al. . Use of the Functional Bowel Disorder Severity Index (FBDSI) in a study of patients with the irritable bowel syndrome and fibromyalgia Am J Gastroenterol. 2000;95:995-998.
12 Lee OY, Mayer EA, Schmulson M, Chang L, Naliboff B. Gender-related differences in IBS symptoms Am J Gastroenterol. 2001;96:2184-2193.
13 Thakur ER, Gurtman MB, Keefer L, Brenner DM, Lackner JM, Representing the IBSOSRG. Gender differences in irritable bowel syndrome: the interpersonal connection Neurogastroenterol Motil. 2015;27:1478-1486.
14 Thakur ER, Quigley BM, El-Serag HB, Gudleski GD, Lackner JM. Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age J Psychosom Res. 2016;88:48-53.
15 Le Pluart D, Sabate JM, Bouchoucha M, Hercberg S, Benamouzig R, Julia C. Functional gastrointestinal disorders in 35,447 adults and their association with body mass index Aliment Pharmacol Ther. 2015;41:758-767.
Torres MJ, Sabate JM, Bouchoucha M, Buscail C, Hercberg S, Julia C. Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Sante study. Therap Adv Gastroenterol. 2018;11:1756283X17746625.
17 Hajishafiee M, Keshteli AH, Saneei P, Feinle-Bisset C, Esmaillzadeh A, Adibi P. Healthy lifestyle score and irritable bowel syndrome: A cross-sectional study in adults Neurogastroenterol Motil. 2020:e13793.
18 Bouchoucha M, Fysekidis M, Rompteaux P, Airinei G, Sabate JM, Benamouzig R. Influence of Age and Body Mass Index on Total and Segmental Colonic Transit Times in Constipated Subjects J Neurogastroenterol Motil. 2019;25:258-266.
19 Fond G, Loundou A, Hamdani Net al. . Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis Eur Arch Psychiatry Clin Neurosci. 2014;264:651-660.
20 Agachan F, Chen T, Pfeifer J, Reissman P, Wexner SD. A constipation scoring system to simplify evaluation and management of constipated patients Dis Colon Rectum. 1996;39:681-685.
21 Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress Aliment Pharmacol Ther. 1997;11:395-402.
22 Varma MG, Wang JY, Berian JR, Patterson TR, McCrea GL, Hart SL. The constipation severity instrument: a validated measure Dis Colon Rectum. 2008;51:162-172.
23 Kichline T, Cushing CC, Ortega A, Friesen C, Schurman JV. Associations Between Physical Activity and Chronic Pain Severity in Youth With Chronic Abdominal Pain Clin J Pain. 2019;35:618-624.
24 Jiang X, Locke GR, 3rd, Choung RS, Zinsmeister AR, Schleck CD, Talley NJ. Prevalence and risk factors for abdominal bloating and visible distention: a population-based study Gut. 2008;57:756-763.
25 Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders Gastroenterology. 2006;130:1480-1491.
26 Lacy BE, Mearin F, Chang Let al. . Bowel Disorders Gastroenterology. 2016;150:1393-1407.
27 Bouchoucha M, Devroede G, Mary F, Bon C, Bejou B, Benamouzig R. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation Dig Dis Sci. 2018;63:1763-1773.
28 Wong RK, Palsson OS, Turner MJet al. . Inability of the Rome III criteria to distinguish functional constipation from constipation-subtype irritable bowel syndrome Am J Gastroenterol. 2010;105:2228-2234.
29 Clouse RE, Mayer EA, Aziz Qet al. . Functional abdominal pain syndrome Gastroenterology. 2006;130:1492-1497.
30 Bouchoucha M, Hejnar M, Devroede G, Babba T, Bon C, Benamouzig R. Anxiety and depression as markers of multiplicity of sites of functional gastrointestinal disorders: a gender issue? Clin Res Hepatol Gastroenterol. 2013;37:422-430.
31 Singh P, Lee HN, Rangan Vet al. . Similarities in Clinical and Psychosocial Characteristics of Functional Diarrhea and Irritable Bowel Syndrome With Diarrhea Clin Gastroenterol Hepatol. 2020;18:399-405 e391.
32 Chang L, Chey WD, Drossman Det al. . Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation Aliment Pharmacol Ther. 2016;44:1114-1122.
33 Hod K, Ringel Y, van Tilburg MAL, Ringel-Kulka T. Bloating in Irritable Bowel Syndrome Is Associated with Symptoms Severity, Psychological Factors, and Comorbidities Dig Dis Sci. 2019;64:1288-1295.
34 Vulevic J, Tzortzis G, Juric A, Gibson GR. Effect of a prebiotic galactooligosaccharide mixture (B-GOS(R)) on gastrointestinal symptoms in adults selected from a general population who suffer with bloating, abdominal pain, or flatulence Neurogastroenterol Motil. 2018;30:e13440.
35 Wong MYW, Hebbard G, Gibson PR, Burgell RE. Chronic constipation and abdominal pain: Independent or closely interrelated symptoms? J Gastroenterol Hepatol. 2020.
36 Heaton KW, O'Donnell LJ. An office guide to whole-gut transit time. Patients' recollection of their stool form J Clin Gastroenterol. 1994;19:28-30.
37 Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit Gastroenterology. 2006;131:1003-1010.
38 Eslick GD. Gastrointestinal symptoms and obesity: a meta-analysis Obes Rev. 2012;13:469-479.
39 Drossman DA, Li Z, Andruzzi Eet al. . U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact Dig Dis Sci. 1993;38:1569-1580.
40 Tang YR, Yang WW, Liang ML, Xu XY, Wang MF, Lin L. Age-related symptom and life quality changes in women with irritable bowel syndrome World J Gastroenterol. 2012;18:7175-7183.
41 Blanchard EB, Scharff L, Schwarz SP, Suls JM, Barlow DH. The role of anxiety and depression in the irritable bowel syndrome Behav Res Ther. 1990;28:401-405.
42 Sibelli A, Chalder T, Everitt H, Workman P, Windgassen S, Moss-Morris R. A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset Psychol Med. 2016;46:3065-3080.
43 Van Oudenhove L, Tornblom H, Storsrud S, Tack J, Simren M. Depression and Somatization Are Associated With Increased Postprandial Symptoms in Patients With Irritable Bowel Syndrome Gastroenterology. 2016;150:866-874.
44 Lee C, Doo E, Choi JMet al. . The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis J Neurogastroenterol Motil. 2017;23:349-362.
45 Bouchoucha M, Fysekidis M, Devroede G, Raynaud JJ, Bejou B, Benamouzig R. Abdominal pain localization is associated with non-diarrheic Rome III functional gastrointestinal disorders Neurogastroenterol Motil. 2013;25:686-693.
46 Shah ED, Almario CV, Spiegel BM, Chey WD. Presentation and Characteristics of Abdominal Pain Vary by Irritable Bowel Syndrome Subtype: Results of a Nationwide Population-Based Study Am J Gastroenterol. 2020;115:294-301.
Funding
No funding source.
Author information
Authors and Affiliations
Contributions
Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work: BOUCHOUCHA, DEUTSCH. Drafting the article or revising it critically for important intellectual content: BOUCHOUCHA, SABATE, UZAN. Final approval of the version to be published: BOUCHOUCHA, DEUTSCH, UZAN, RAYNAUD, SABATE, BENAMOUZIG. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: BOUCHOUCHA, DEUTSCH, UZAN, RAYNAUD, SABATE, BENAMOUZIG.
Corresponding author
Ethics declarations
Conflict of interest
None to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
10620_2021_7175_MOESM1_ESM.jpg
Flowchart of patient selection. Abbreviations: FGID: Functional Gastrointestinal disorders; FBD: Functional Bowel Disorders; FAP: Functional Abdominal Pain (JPG 327 kb)
Rights and permissions
About this article
Cite this article
Deutsch, D., Bouchoucha, M., Uzan, J. et al. Abdominal Pain Severity Is Mainly Associated with Bloating Severity in Patients with Functional Bowel Disorders and Functional Abdominal Pain. Dig Dis Sci 67, 3026–3035 (2022). https://doi.org/10.1007/s10620-021-07175-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-021-07175-z